bluebird bio Inc (DELISTED) (BLUE:DL)
4.97
0.00 (0.00%)
USD |
NASDAQ |
Jun 06, 16:00
bluebird bio Shareholders Equity (Quarterly): -57.87M for March 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 50.95B |
| CervoMed, Inc. | 26.01M |
| RxSight, Inc. | 275.97M |
| Protalix Biotherapeutics, Inc. | 52.91M |
| Armata Pharmaceuticals, Inc. | -95.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 295.96M |
| Total Liabilities (Quarterly) | 353.82M |
| Debt to Equity Ratio | -1.252 |
| Current Ratio | 0.5539 |
| Net Debt Paydown Yield | -30.34% |